These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8326139)

  • 21. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
    Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
    J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of collagen arthritis after in vivo treatment with a syngeneic monoclonal anti-idiotypic antibody to a cross-reactive idiotope on collagen II auto-antibodies.
    Nordling C; Holmdahl R; Klareskog L
    Immunology; 1991 Apr; 72(4):486-90. PubMed ID: 2037311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine.
    Tarkowski A; Sun JB; Holmdahl R; Holmgren J; Czerkinsky C
    Arthritis Rheum; 1999 Aug; 42(8):1628-34. PubMed ID: 10446861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
    Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
    Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    Smith RJ; Sly LM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.
    Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE
    Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Z-4',5'-didehydro-5'-deoxy-5'-fluoroadenosine (MDL 28,842), an irreversible inhibitor of S-adenosylhomocysteine hydrolase, suppresses proliferation of cultured keratinocytes and squamous carcinoma cell lines.
    Paller AS; Arnsmeier SL; Clark SH; Mirkin BL
    Cancer Res; 1993 Dec; 53(24):6058-60. PubMed ID: 8261422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.
    Higuchi K; Kweon MN; Fujihashi K; McGhee JR; Kiyono H
    J Rheumatol; 2000 Apr; 27(4):1038-44. PubMed ID: 10782834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylacetylenic putrescine (MAP), an inhibitor of polyamine biosynthesis, prevents the development of collagen-induced arthritis.
    Wolos JA; Logan DE; Bowlin TL
    Cell Immunol; 1990 Feb; 125(2):498-507. PubMed ID: 2297795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
    Chu CQ; Londei M
    J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses.
    Yang YF; Mukai T; Gao P; Yamaguchi N; Ono S; Iwaki H; Obika S; Imanishi T; Tsujimura T; Hamaoka T; Fujiwara H
    Eur J Immunol; 2002 Aug; 32(8):2124-32. PubMed ID: 12209624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
    Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
    Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
    Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
    Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody.
    Banerjee S; Wei BY; Hillman K; Luthra HS; David CS
    J Immunol; 1988 Aug; 141(4):1150-4. PubMed ID: 3135321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
    J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preventive effect of oral administration of type I interferon on collagen-induced arthritis in rats.
    Yoshino S
    Exp Mol Pathol; 1995 Apr; 62(2):123-30. PubMed ID: 8549696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice.
    Jorgensen C; Gedon E; Jaquet C; Sany J
    J Rheumatol; 1998 Apr; 25(4):763-7. PubMed ID: 9558182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.
    Tada Y; Koarada S; Morito F; Ushiyama O; Haruta Y; Kanegae F; Ohta A; Ho A; Mak TW; Nagasawa K
    Arthritis Rheum; 2003 Nov; 48(11):3280-90. PubMed ID: 14613294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
    Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
    Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.